The NOS3 gene plays a fundamental role in vascular endothelium function through the production of nitric oxide, a molecule essential for the regulation of blood tone and flow. Certain genetic variants can modify the activity of the eNOS enzyme and contribute to individual differences in nitric oxide availability.
Gene NOS3
The NOS3 gene (Nitric Oxide Synthase 3) encodes the endothelial nitric oxide synthase (eNOS) enzyme, one of the main enzymes responsible for the production of nitric oxide (NO) in the vascular endothelium. Nitric oxide is an essential signaling molecule for the maintenance of vascular function, as it participates in the regulation of blood vessel tone, blood flow, endothelial function, and various processes related to cardiovascular homeostasis.
Adequate nitric oxide production contributes to the maintenance of an appropriate physiological vascular response to the metabolic demands of the body.
The rs1799983 variant, also known as Glu298Asp, is one of the most studied polymorphisms of the NOS3 gene. This variant produces an amino acid substitution in the eNOS protein and has been studied for its possible association with differences in enzyme activity and nitric oxide availability.
Genes analyzed
Bibliography
Cotta Filho CK, Oliveira-Paula GH, Rondon Pereira VC, Lacchini R. Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response. Expert Opin Drug Metab Toxicol. 2020 Oct;16(10):927-951.
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms. Gene. 2016 Jan 10;575(2 Pt 3):584-99.
Shi J, Liu S, Guo Y, et al. Association between eNOS rs1799983 polymorphism and hypertension: a meta-analysis involving 14,185 cases and 13,407 controls. BMC Cardiovasc Disord. 2021 Aug 9;21(1):385.
